Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-01-01 @ 9:05 AM
Study NCT ID:
NCT01198535
Status:
TERMINATED
Last Update Posted:
2015-05-18
First Post:
2010-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Colon Mucinous Adenocarcinoma | View |
| None | Colon Signet Ring Cell Adenocarcinoma | View |
| None | Rectal Mucinous Adenocarcinoma | View |
| None | Rectal Signet Ring Cell Adenocarcinoma | View |
| None | Recurrent Colon Carcinoma | View |
| None | Recurrent Rectal Carcinoma | View |
| None | Stage IVA Colon Cancer | View |
| None | Stage IVA Rectal Cancer | View |
| None | Stage IVB Colon Cancer | View |
| None | Stage IVB Rectal Cancer | View |
Keywords: